Medicine & Life Sciences

1. Prostatic Neoplasms 100%
2. Castration 60%
3. Neoplasms 57%
4. rucaparib 39%
5. Atlases 35%
6. Genome 31%
7. Mutation 28%
8. Melanoma 24%
9. Therapeutics 23%
10. Poly(ADP-ribose) Polymerase Inhibitors 23%
11. Prostate-Specific Antigen 21%
12. Survival 20%
13. Renal Cell Carcinoma 19%
14. Abiraterone Acetate 18%
15. Genes 16%
16. Androgens 16%
17. Genomics 16%
18. Network Meta-Analysis 15%
19. Exome 14%
20. Radium-223 14%
21. Neoplasm Metastasis 14%
22. Cell-Free Nucleic Acids 13%
23. Progression-Free Survival 13%
24. Drug Therapy 13%
25. Testicular Germ Cell Tumor 12%
26. Neoplasm Genes 12%
27. Prednisone 12%
28. Clinical Trials 12%
29. abiraterone 11%
30. Systematic Reviews 11%
31. Machine Learning 11%
32. pembrolizumab 11%
33. Immunotherapy 11%
34. olaparib 10%
35. Docetaxel 10%
36. Hormones 10%
37. DNA Repair 9%
38. Androgen Receptors 9%
39. POEMS Syndrome 9%
40. Nivolumab 8%
41. Precision Medicine 8%
42. Confidence Intervals 8%
43. Deep Learning 8%
44. Cryoglobulinemia 8%
45. Long Noncoding RNA 7%
46. Adenocarcinoma 7%
47. MDV 3100 7%
48. Bone Neoplasms 7%
49. taxane 7%
50. Urinary Bladder Neoplasms 6%